BioSpace News Archive

CEL-SCI Corporation (NYSE American: CVM) today reported financial results for the quarter ended March 31, 2024, as well as key recent clinical and corporate developments.

Know Labs, Inc. today announced the appointment of Chris Somogyi as President, International.

Scientific Industries, Inc. (OTCQB:SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, yesterday reported financial results for the three-month period ended March 31, 2024.

A2 Biotherapeutics, Inc. today announced dosing of the first patient in the Phase 1 clinical trial of A2B694.

Trinity Biotech plc announced a strategic collaboration with medical artificial intelligence company PulseAI to enhance the Company’s recently acquired continuous glucose monitor biosensor technology.

Faron Pharmaceuticals Ltd. announces the nomination of its co-founders, Dr. Markku Jalkanen and Dr. Sirpa Jalkanen, as finalists in the ‘SMEs’ category of the European Inventor Award 2024.

Bruker Corporation will host an Investor Webinar from 10 am to about 12 noon Eastern Daylight Time tomorrow May 17, 2024, to provide additional insights into its three recent acquisitions of Chemspeed, ELITech, and of the NanoString business.

Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that it has entered into a definitive agreement to be acquired by Johnson & Johnson

Calliditas Therapeutics AB announced that it will hold an in-person and virtual R&D day on Thursday, May 30, 2024 at 3:00 PM CET.

Kira Pharmaceuticals today announced that it will present positive long-term safety and efficacy results from its Phase 2 study of KP104 in complement inhibitor-naïve patients with PNH in an oral session at the 2024 European Hematology Association (EHA) Hybrid Congress, to be held in Madrid, Spain, from June 13-16, 2024.